PT - JOURNAL ARTICLE AU - Shakaib Hayat AU - Marina N. Magrey TI - Glucocorticoid-induced osteoporosis: Insights for the clinician AID - 10.3949/ccjm.87a.19039 DP - 2020 Jul 01 TA - Cleveland Clinic Journal of Medicine PG - 417--426 VI - 87 IP - 7 4099 - http://www.ccjm.org/content/87/7/417.short 4100 - http://www.ccjm.org/content/87/7/417.full SO - Cleve Clin J Med2020 Jul 01; 87 AB - Glucocorticoids cause significant bone loss, predominantly affecting trabecular bone, with consequent fragility fractures. The risk of fractures is related to the dose and duration of glucocorticoid use, but an increased risk may be observed even at low doses and even in the first month of treatment. Steps to prevent or treat osteoporosis should be considered in all patients who take the equivalent of prednisone at a dose of 2.5 mg or more per day for 3 or more months.